Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Approval granted for patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Isaac “Zak” Kohane is the chair of biomedical informatics at Harvard Medical School. He’s uniquely situated for the explosion ...

As the Trump administration cuts thousands of federal jobs, some fired workers worry about health agencies' ability to ...

To get FDA approval, scientists must be able to demonstrate ... a professor in the Department of Environmental Health and Engineering at Johns Hopkins Bloomberg School of Public Health.

Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

A new oral antibiotic, gepotidacin, may treat gonorrhea. The gepotidacin FDA approval may help this drug reach those who need ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...